A detailed history of Global Financial Private Client, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 88 shares of BIO stock, worth $29,296. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88
Previous 14 528.57%
Holding current value
$29,296
Previous $3.82 Million 669.95%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$263.97 - $344.64 $19,533 - $25,503
74 Added 528.57%
88 $29.4 Million
Q2 2020

May 15, 2024

BUY
$334.87 - $493.06 $1,674 - $2,465
5 Added 55.56%
14 $6.36 Million
Q4 2019

May 15, 2024

BUY
$319.73 - $374.2 $2,877 - $3,367
9 New
9 $3.33 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.